UNIVERSITY AT BUFFALO

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
1846-01-01
Employees
5.2K
Market Cap
-
Website
https://www.buffalo.edu/
Clinical Trials
Related News

Sitagliptin in Type I Diabetic Patients

Not Applicable
Withdrawn
Conditions
Diabetes Type I
Interventions
Drug: Placebo
Drug: sitagliptin
First Posted Date
2012-12-04
Last Posted Date
2022-03-24
Lead Sponsor
University at Buffalo
Registration Number
NCT01741103
Locations
๐Ÿ‡บ๐Ÿ‡ธ

115 Flint Road, Williamsville, New York, United States

Liraglutide in the Treatment of Type 1 Diabetes Mellitus

Phase 3
Completed
Conditions
Type 1 Diabetes
Interventions
Drug: Placebo
Drug: Liraglutide
First Posted Date
2012-11-06
Last Posted Date
2024-01-05
Lead Sponsor
University at Buffalo
Target Recruit Count
72
Registration Number
NCT01722266
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Diabetes-Endocrinology Center of Western NY, Williamsville, New York, United States

Liraglutide in Type 1 Diabetes

Phase 3
Completed
Conditions
Type 1 Diabetes
Interventions
Drug: Liraglutide 1.8mg
Drug: Placebo
First Posted Date
2012-11-06
Last Posted Date
2024-01-23
Lead Sponsor
University at Buffalo
Target Recruit Count
69
Registration Number
NCT01722240
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Diabetes-Endocrinology Center of WNY, Buffalo, New York, United States

Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes

Phase 3
Withdrawn
Conditions
Type 1 Diabetes
Interventions
Drug: Placebo
Drug: Liraglutide
First Posted Date
2012-11-06
Last Posted Date
2017-02-09
Lead Sponsor
University at Buffalo
Registration Number
NCT01722227
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Diabetes-Endocrinology Center of WNY, Williamsville, New York, United States

A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months

Completed
Conditions
Multiple Sclerosis
Interventions
Other: MRI
First Posted Date
2012-09-28
Last Posted Date
2013-03-25
Lead Sponsor
University at Buffalo
Target Recruit Count
60
Registration Number
NCT01695434
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Buffalo Neuroimaging Analysis Center, Buffalo, New York, United States

Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study

First Posted Date
2012-06-26
Last Posted Date
2016-02-12
Lead Sponsor
University at Buffalo
Target Recruit Count
159
Registration Number
NCT01628315
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Buffalo Neuroimaging Analysis Center, Buffalo, New York, United States

Evaluation of Brain Atrophy in CIS Patients on Avonex

Completed
Conditions
Multiple Sclerosis
First Posted Date
2012-05-07
Last Posted Date
2014-07-09
Lead Sponsor
University at Buffalo
Target Recruit Count
180
Registration Number
NCT01592474

To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects

Not Applicable
Completed
Conditions
Inflammation
Interventions
Drug: Placebo
Drug: Vytorin
First Posted Date
2011-08-19
Last Posted Date
2024-04-17
Lead Sponsor
University at Buffalo
Target Recruit Count
20
Registration Number
NCT01420328
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Diabetes Endocrinology Center of WNY, Buffalo, New York, United States

Influence of a Computer Game on Youth's Choices of Activities

First Posted Date
2011-08-04
Last Posted Date
2022-04-14
Lead Sponsor
University at Buffalo
Target Recruit Count
80
Registration Number
NCT01409629
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Division of Behavioral Medicine, Buffalo, New York, United States

The Jewels in Our Genes Study - an African American Family Study of Breast Cancer

Completed
Conditions
Breast Cancer
First Posted Date
2011-06-27
Last Posted Date
2016-05-11
Lead Sponsor
University at Buffalo
Target Recruit Count
330
Registration Number
NCT01380925
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University at Buffalo, Buffalo, New York, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy